StonvexLoading…
StonvexStonvexStonvexCore line items from MDXG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $58.99M | $418.63M | $300.54M | $186.81M |
Operating Income | $-16.05M | $63.89M | $42.81M | $20.62M |
Net Income | $-10.86M | $48.58M | $33.39M | $16.64M |
EPS (Diluted) | $-0.07 | $0.32 | $0.22 | $0.11 |
Total Assets | $308.68M | $342.65M | $318.99M | $291.11M |
Total Liabilities | $65.74M | $86.11M | $80.04M | $74.48M |
Cash & Equivalents | $159.77M | $166.12M | $142.08M | $118.87M |
Free Cash Flow OCF − CapEx | $1.31M | $72.97M | $48.30M | $19.16M |
Shares Outstanding | 148.93M | 148.09M | 148.08M | 147.92M |